Biopharma Kiromic is a Houston-based company focused on revolutionizing cancer treatment through the development of immunotherapy drugs. With a technology pipeline managed by a team of experienced leaders and guided by a scientific advisory board, the company aims to address the high percentage of cancer deaths in the US that could potentially be treated with immunotherapy. However, the company acknowledges the challenges associated with immunotherapy, including poor response rates, toxicities, and off-target effects that can harm normal cells.
At Biopharma Kiromic, cutting-edge research and development take place in state-of-the-art facilities and labs. The company is committed to advancing the field of immunotherapy through publications, presentations, and participation in industry events. With a focus on investor support, Biopharma Kiromic strives to make a significant impact in the fight against cancer.
Generated from the website